L-carnitine agent
    1.
    发明授权
    L-carnitine agent 有权
    左旋肉碱剂

    公开(公告)号:US06472011B1

    公开(公告)日:2002-10-29

    申请号:US09923849

    申请日:2001-08-07

    IPC分类号: A61K3114

    摘要: An L-carnitine agent has an indispensable function in the body and utility as a material for pharmaceutical agents or food and drink. By subjecting milk or modified milk products of mammals from which casein is removed, to the treatment of desalting and partial removal of lactose followed by drying, L-carnitine content, lactose content, and ash content are adjusted to 0.1˜100 mmol/100 g, 20˜95 g/100 g, and 5 g/100 g or less, respectively.

    摘要翻译: 左旋肉碱剂在身体和作为药剂或食品和饮料的材料中具有不可或缺的功能。 通过将除去酪蛋白的哺乳动物的牛奶或改性乳制品进行脱盐处理和部分除去乳糖,然后干燥,将L-肉碱含量,乳糖含量和灰分调节至0.1〜100mmol / 100g ,20〜95g / 100g,5g / 100g以下。

    Antimicrobial treatment for herpes simplex virus and other infectious diseases
    2.
    发明授权
    Antimicrobial treatment for herpes simplex virus and other infectious diseases 失效
    单纯疱疹病毒等感染性疾病的抗菌治疗

    公开(公告)号:US06355684B1

    公开(公告)日:2002-03-12

    申请号:US08646988

    申请日:1996-05-08

    申请人: Meryl Squires

    发明人: Meryl Squires

    IPC分类号: A61K3114

    摘要: An improved medical treatment and medicine is provided to quickly and safely resolve herpes and other microbial infections. The inexpensive user-friendly medicine can be applied and maintained on the infected region until the physical symptoms of the disease disappears and the patient is comfortable and has a normal appearance. The attractive medicine comprises an antimicrobial concentrate comprising microbe inhibitors, phytochemicals or isolates. Desirably, the effective medicine comprises a surfactant and an aqueous carrier or solvent. In the preferred form, the medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution.

    摘要翻译: 提供改进的医疗和药物以快速和安全地解决疱疹和其他微生物感染。 廉价的用户友好型药物可以应用和维持在受感染的区域,直到疾病的身体症状消失,患者舒适并具有正常的外观。 有吸引力的药物包括包含微生物抑制剂,植物化学物质或分离物的抗微生物浓缩物。 理想地,有效药物包括表面活性剂和水性载体或溶剂。 在优选形式中,药物包括紫苏科植物化学药物和苯扎氯铵在无菌水溶液中。

    Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
    7.
    发明授权
    Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism 失效
    药物组合物包含链烷酰基L-肉毒碱与用于治疗由脂质代谢改变引起的病态的他汀类药物组合

    公开(公告)号:US06180680B2

    公开(公告)日:2001-01-30

    申请号:US09446806

    申请日:1999-12-28

    申请人: Claudio Cavazza

    发明人: Claudio Cavazza

    IPC分类号: A61K3114

    摘要: Coordinated use of an alkanoyl L-carnitine such as propionyl L-carnitine and a statin such as simvastatin is described for treating pathologies resulting from altered lipid metabolism. Coordinated use of the two ingredients is achieved by substantial contemporaneous co-administration of the two active ingredients or by administering a combination composition containing a mixture of the two active ingredients.

    摘要翻译: 描述了用于治疗由脂质代谢改变引起的病理学的链烷酰基L-肉毒碱如丙酰基左旋肉碱和他汀类药物如辛伐他汀的协同使用。 通过两种活性成分的大量同时共同施用或通过施用含有两种活性成分的混合物的组合组合物来实现两种成分的协调使用。

    Ionic polymers as anti-infective agents
    8.
    发明授权
    Ionic polymers as anti-infective agents 有权
    离子聚合物作为抗感染剂

    公开(公告)号:US06767549B2

    公开(公告)日:2004-07-27

    申请号:US10374014

    申请日:2003-02-25

    IPC分类号: A61K3114

    摘要: A method for treating a microbial infection in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising an amino group or an ammonium group attached to the polymer backbone via an aliphatic spacer group. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer comprising a monomer having a pendant ammonium group and a hydrophobic monomer.

    摘要翻译: 一种用于治疗哺乳动物例如人的微生物感染的方法,包括用治疗有效量的包含通过脂肪族间隔基连接到聚合物主链的氨基或铵基团的聚合物来治疗哺乳动物。 聚合物可以是均聚物或共聚物。 在一个实施方案中,聚合物是包含具有侧铵基团和疏水单体的单体的共聚物。

    Unit galenical formulation for vaginal use as a local contraceptive and/or to combat sexually-transmitted diseases and/or HIV
    10.
    发明授权
    Unit galenical formulation for vaginal use as a local contraceptive and/or to combat sexually-transmitted diseases and/or HIV 失效
    用于阴道用作本地避孕药和/或抗击性传播疾病和/或艾滋病毒的单位盖仑制剂

    公开(公告)号:US06664296B1

    公开(公告)日:2003-12-16

    申请号:US08860222

    申请日:1997-08-19

    IPC分类号: A61K3114

    CPC分类号: A61K9/0034

    摘要: This galenical formulation which comprises first an outer envelope including gelatin and secondly a non-aqueous liquid or semi-liquid internal phase containing an active principle in solution is characterized in that the active principle is constituted by a spermicide and in that the internal phase includes, in addition to the active principle: a major proportion of a lipophilic agent compatible with the rubber latex of a condom; in minor proportion at least one hydrodispersible agent; at least one bioadhesion agent; and at least one agent for gelling the lipophilic agent. This galenical formulation for vaginal use provides the known advantages of the soft capsule, having properties that are simultaneously spermicidal, antiseptic, and lubricating, and in addition it is reliably compatible with condoms, without any risk of damaging the rubber latex thereof.

    摘要翻译: 这种盖仑制剂首先包括包含明胶的外封套,其次包括在溶液中含有活性成分的非水性液体或半液体内相,其特征在于活性成分由杀精剂构成,其中内相包括, 除了活性成分外:主要成分是与安全套的橡胶胶相容的亲脂剂; 至少一种水分散剂; 至少一种生物粘附剂; 和至少一种用于胶凝亲脂性试剂的试剂。 这种用于阴道用途的盖仑制剂提供了软胶囊的已知优点,具有同时杀精,消毒和润滑的性质,此外它可靠地与避孕套相容,而没有损害其橡胶胶乳的风险。